Publications by authors named "Gabriel Panayi"

Claim this Profile
T
The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients.
Christopher Hall, Jill Pleasance, Oliver Hickman, Bruce Kirkham, Gabriel S Panayi

Int J Mol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding Immunoglobulin Protein (BIP) Inhibits TNF-α-Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model.
Mario M Zaiss, Christopher Hall, Neil W A McGowan, Rebecca Babb, Vikesh Devlia, Gabriel S Panayi

ACR Open Rheumatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis.
Nicola J Gullick, Fowzia Ibrahim, Ian C Scott, Alexandra Vincent, Andrew P Cope, Gabriel S Panayi

BMC Rheumatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis.
Bruce Kirkham, Khaldoun Chaabo, Christopher Hall, Toby Garrood, Timothy Mant, Gabriel S Panayi

Rheumatology (Oxford)· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin heavy-chain-binding protein (BiP): a stress protein that has the potential to be a novel therapy for rheumatoid arthritis.
Gabriel S Panayi, Valerie M Corrigall

Biochem Soc Trans· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
Rocky Strollo, Frederique Ponchel, Vivianne Malmström, Paola Rizzo, Michele Bombardieri, Gabriel S Panayi

Arthritis Rheum· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding immunoglobulin protein resolves rheumatoid synovitis: a xenogeneic study using rheumatoid arthritis synovial membrane transplants in SCID mice.
Kaoru Yoshida, Akira Ochiai, Hiroaki Matsuno, Gabriel S Panayi, Valerie M Corrigall

Arthritis Res Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?
Adrian M Shields, Gabriel S Panayi, Valerie M Corrigall

Front Immunol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns.
Adrian M Shields, Stephen J Thompson, Gabriel S Panayi, Valerie M Corrigall

Rheumatology (Oxford)· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years.
Nicola J Gullick, Stephen P Oakley, Amir Zain, Terence Gibson, Tim Jones, Gabriel S Panayi

Rheumatology (Oxford)· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments in the immunology of rheumatoid arthritis, a personal perspective.
Gabriel S Panayi

Rheumatology (Oxford)· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microchimerism of the shared epitope in rheumatoid arthritis: comment on the article by Rak et al.
Gabriel S Panayi

Arthritis Rheum· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapy.
Alyssa M Macedo, Stephen P Oakley, Gabriel S Panayi, Bruce W Kirkham

Arthritis Rheum· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding immunoglobulin protein-treated peripheral blood monocyte-derived dendritic cells are refractory to maturation and induce regulatory T-cell development.
Valerie M Corrigall, Olivier Vittecoq, Gabriel S Panayi

Immunology· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BiP, an anti-inflammatory ER protein, is a potential new therapy for the treatment of rheumatoid arthritis.
Gabriel S Panayi, Valerie M Corrigall

Novartis Found Symp· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein.
Rebecca J Brownlie, Linda K Myers, Paul H Wooley, Valerie M Corrigall, Mark D Bodman-Smith, Gabriel S Panayi

Arthritis Rheum· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Even though T-cell-directed trials have been of limited success, is there reason for optimism?
Gabriel S Panayi

Nat Clin Pract Rheumatol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.
Ahuva Nissim, Paul G Winyard, Valerie Corrigall, Rewas Fatah, David Perrett, Gabriel Panayi

Arthritis Rheum· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
Andrew M Woods, Stephen J Thompson, Paul H Wooley, Gabriel Panayi, Linda S Klavinskis

Arthritis Rheum· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study.
Bo Baslund, Niels Tvede, Bente Danneskiold-Samsoe, Per Larsson, Gabriel Panayi

Arthritis Rheum· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cell-directed therapy in rheumatoid arthritis--clinical experience.
Gabriel S Panayi

J Rheumatol Suppl· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress cytokines: pivotal proteins in immune regulatory networks; Opinion.
Gabriel S Panayi, Valerie M Corrigall, Brian Henderson

Curr Opin Immunol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BiP: a new biologic immunomodulator for the treatment of rheumatoid arthritis.
Gabriel Panayi, Valerie Corrigall

Autoimmun Rev· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
Valerie M Corrigall, Mark D Bodman-Smith, Melanie Brunst, Hannah Cornell, Gabriel S Panayi

Arthritis Rheum· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantigens and immune pathways in rheumatoid arthritis.
Valerie M Corrigall, Gabriel S Panayi

Crit Rev Immunol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis